Version 5.4
Bos taurus Gene: SEC22A
Summary
InnateDB Gene IDBG-633386.3
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol SEC22A
Gene Name vesicle-trafficking protein SEC22a
Synonyms
Species Bos taurus
Ensembl Gene ENSBTAG00000014797
Encoded Proteins
IDBP-685098
vesicle-trafficking protein SEC22a
Protein Structure
Useful resources Stemformatics EHFPI ImmGen
Entrez Gene
Summary This gene does not have any Entrez summary - the following is the summary from its human ortholog ENSG00000121542:
The protein encoded by this gene belongs to the member of the SEC22 family of vesicle trafficking proteins. This protein has similarity to rat SEC22 and may act in the early stages of the secretory pathway. [provided by RefSeq, Nov 2008]
Gene Information
Type Protein coding
Genomic Location Chromosome 1:68170572-68232640
Strand Forward strand
Band
Transcripts
ENSBTAT00000019691 ENSBTAP00000019691
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
They are also associated with 2 interaction(s) predicted by orthology.
Predicted by orthology
Total 2 [view]
Gene Ontology

Molecular Function
Accession GO Term
Biological Process
GO:0006810 transport
Cellular Component
GO:0016020 membrane
Orthologs
Species
Homo sapiens
Mus musculus
Gene ID
Gene Order
ENSG00000121542
View Gene Order
ENSMUSG00000034473
View Gene Order
Cross-References
SwissProt
TrEMBL F1N2T5
UniProt Splice Variant
Entrez Gene 532730
UniGene Bt.3295
RefSeq NM_001083462
HUGO
OMIM
CCDS
HPRD
IMGT
EMBL DAAA02001613 DAAA02001614 DAAA02001615
GenPept
RNA Seq Atlas 532730

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca